Transcriptomics

Dataset Information

0

Early introduction of oral paricalcitol in renal transplant recipients.


ABSTRACT: In stable renal transplant recipients with hyperparathyroidism, the vitamin D agonist paricalcitol reduces the level of proteinuria. Animal studies have indicated possible anti-fibrotic and anti-inflammatory effects of paricalcitol. We hypothesised that early introduction of paricalcitol in de novo renal transplant recipients would reduce proteinuria and counteract development of fibrosis in the allograft.

ORGANISM(S): Homo sapiens

PROVIDER: GSE83486 | GEO | 2017/09/01

SECONDARY ACCESSION(S): PRJNA326120

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2017-09-01 | E-GEOD-83486 | biostudies-arrayexpress
| PRJNA1054489 | ENA
2022-06-02 | GSE205122 | GEO
| PRJNA290675 | ENA
| PRJNA843961 | ENA
2010-12-22 | GSE14630 | GEO
2012-01-09 | E-GEOD-26627 | biostudies-arrayexpress
| EGAS00001006257 | EGA
| PRJEB32082 | ENA
| EGAS00001006258 | EGA